BUSINESS
Jazz Pharmaceuticals Buys Actio Biosciences for $1.32B
Jazz Pharmaceuticals is acquiring Actio Biosciences in a $1.32 billion deal, expanding its pharmaceutical portfolio.
EDITOR'S PICKS
Markets
View all 6 →Economy
View all 1 →Business
View all 6 →Policy
View all 4 →Personal Finance
View all 3 →
MOST READ
-
1
BUSINESS
Jazz Pharmaceuticals Buys Actio Biosciences for $1.32B
-
2
BUSINESS
OpenGate Capital to Acquire Maersk's Global Safety Training Unit
-
3
PERSONAL FINANCE
HELOC vs. Home Equity Loan Rates: What to Know Today
-
4
MARKETS
What Bitcoin's BIP-110 Debate Tells Us About Crypto Markets
-
5
BUSINESS
GameStop Eyes eBay Collaboration Instead of Full Takeover